Rock Springs Capital Management LP Blueprint Medicines Corp Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Rock Springs Capital Management LP holds 1,096,899 shares of BPMC stock, worth $99.5 Million. This represents 3.82% of its overall portfolio holdings.
Number of Shares
1,096,899
Previous 768,776
42.68%
Holding current value
$99.5 Million
Previous $71.1 Million
34.59%
% of portfolio
3.82%
Previous 2.42%
Shares
30 transactions
Others Institutions Holding BPMC
# of Institutions
379Shares Held
61.6MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$615 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$603 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$515 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$227 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$176 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.42B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...